Form4.ai tracks every SEC insider trade in real time. See every LTGO insider filing with a free account — no card.
See every LTGO insider filing — free account, no card.
Free accountLatigo Biotherapeutics, Inc. (LTGO) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $5.0M. Most recent filing: Aug. 12, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 12, 2026 SEC filing | 5AM Ventures VI, L.P. 10% Owner | Conversion | — | — |
| Aug 12, 2026 SEC filing | Sanofi 10% Owner | Conversion | — | — |
| Aug 11, 2026 SEC filing | Westlake BioPartners Fund I, L.P. 10% Owner | Conversion | — | — |
Create a free account to see all 7 LTGO filings from the last 90 days. No card needed.
Create free accountWant LTGO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.